BPI France and Omnes Capital have led a €12m series-A round for French biotechnology company AlgoTherapeutix.
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Intention to list comes four years after the GP acquired the company via its fourth fund
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs
Platform will enable smaller investors to put their secondaries stakes up for sale